By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Breckenridge Pharmaceutical, Inc. 

1141 S. Rogers Circle
Suite 3
Boca Raton  Florida  33487  U.S.A.
Phone: 800-367-3395 Fax: 561-989-9747


SEARCH JOBS


Industry
Pharmaceutical






Company News
Breckenridge Pharmaceutical, Inc. Signs Multi-Product Generic Agreement With MSN Laboratories Pvt. Ltd. 12/22/2014 7:34:55 AM
Breckenridge Pharmaceutical, Inc. Signs Multi-Product Generic Agreement With Pharmaceutics International, Inc. 11/25/2014 1:55:13 PM
Breckenridge Pharmaceutical, Inc. Announces Appointment of New President 11/20/2014 12:38:26 PM
Breckenridge Pharmaceutical, Inc. Announces Approval Of QUETIAPINE FUMARATE TABLETS 11/3/2014 9:28:13 AM
Breckenridge Pharmaceutical, Inc. Announces Approval of Mefenamic Acid Capsules, USP 250mg 10/14/2014 8:59:59 AM
Breckenridge Pharmaceutical, Inc. Announces Paragraph IV ANDA Litigation With Novartis AG (NVS) For Its ANDA Everolimus Oral Tablets (Zortress┬«) 9/5/2014 10:32:31 AM
Breckenridge Pharmaceutical, Inc. Announces Approval For Duloxetine Delayed-Release Capsules 6/13/2014 10:48:04 AM
Pernix Therapeutics, Inc. (PTX) Completes Divesture of Non-Core Assets to Breckenridge Pharmaceutical, Inc. 9/12/2013 10:06:56 AM
Breckenridge Pharmaceutical, Inc. Completes Acquisition of Certain Cypress Products From Pernix Therapeutics, Inc. (PTX) 9/12/2013 9:10:13 AM
Breckenridge Pharmaceutical, Inc. Buys Certain Cypress Pharmaceutical Assets From Pernix Therapeutics, Inc. (PTX) for $30 Million 8/9/2013 6:40:51 AM
12345
//-->